Latest data from KEYNOTE 42: Pembrolizumab vs chemotherapy in treatment-naive patients (pts) with PD-L1 advanced NSCLC
Latest data from KEYNOTE 42: Pembrolizumab vs chemotherapy in treatment-naive patients (pts) with PD-L1 advanced NSCLC
Using CT imaging to find radiomic signatures in surgically resected NSCLC
Risk factors for prostate cancer in men of African descent
Trends in breast cancer incidence and risk
Clinical trials in Africa: Bench to bedside
How do clinicians rate patient’s performance status using ECOG performance scale?
Perception of tobacco use in young adults of urban India
ASCO GU 2019 renal highlights
BGICC 2019
History and current status of breast cancer treatment in Sweden
Can we cure cervical cancer?
Surgical choices for early breast cancer: a cross-sectional survey in 110 hospitals in mainland China